Three-Year Clinical Outcomes of Everolimus-Eluting Stents From the Post-Marketing Surveillance Study of Cobalt-Chromium Everolimus-Eluting Stent (XIENCE V/PROMUS) in Japan
Keyword(s):
2017 ◽
Vol 33
(4)
◽
pp. 313-320
◽
Keyword(s):
2015 ◽
Vol 2
(1)
◽
pp. 16-22
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 83
(1)
◽
pp. 201-207
◽